235 related articles for article (PubMed ID: 33793649)
1. Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease.
Wakabayashi SI; Joshita S; Kimura K; Motoki H; Kobayashi H; Yamashita Y; Sugiura A; Yamazaki T; Kuwahara K; Umemura T
PLoS One; 2021; 16(4):e0249435. PubMed ID: 33793649
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients.
Li J; Zhuang Q; Zhang X; Zheng Y; Qiao Z; Zhang J; Shen X; Shen J
Can Respir J; 2018; 2018():9629570. PubMed ID: 30319722
[TBL] [Abstract][Full Text] [Related]
3. Portopulmonary hypertension.
Al-Naamani N; Roberts KE
Clin Chest Med; 2013 Dec; 34(4):719-37. PubMed ID: 24267301
[TBL] [Abstract][Full Text] [Related]
4. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
Takahashi Y; Yamamoto K; Sakao S; Takeuchi T; Suda R; Tanabe N; Tatsumi K
BMC Pulm Med; 2021 Mar; 21(1):89. PubMed ID: 33726742
[TBL] [Abstract][Full Text] [Related]
5. Symptom-based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease.
Wakabayashi SI; Joshita S; Kimura K; Motoki H; Okumura T; Kobayashi H; Yamashita Y; Sugiura A; Yamazaki T; Kimura T; Kuwahara K; Umemura T
JGH Open; 2023 Aug; 7(8):527-536. PubMed ID: 37649859
[TBL] [Abstract][Full Text] [Related]
6. Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry.
Lazaro Salvador M; Quezada Loaiza CA; Rodríguez Padial L; Barberá JA; López-Meseguer M; López-Reyes R; Sala-Llinas E; Alcolea S; Blanco I; Escribano-Subías P;
Intern Med J; 2021 Mar; 51(3):355-365. PubMed ID: 31943676
[TBL] [Abstract][Full Text] [Related]
7. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
[TBL] [Abstract][Full Text] [Related]
8. Portopulmonary hypertension.
Lv Y; Han G; Fan D
Scand J Gastroenterol; 2016 Jul; 51(7):795-806. PubMed ID: 27002212
[TBL] [Abstract][Full Text] [Related]
9. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
DuBrock HM
Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
[TBL] [Abstract][Full Text] [Related]
10. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary hypertension in liver diseases].
Savale L; Sattler C; Sitbon O
Presse Med; 2014 Sep; 43(9):970-80. PubMed ID: 25148949
[TBL] [Abstract][Full Text] [Related]
12. Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension.
Chiva T; Ripoll C; Sarnago F; Rincón D; Gómez-Camarero J; Galindo E; Catalina MV; Elizaga J; Bañares R
Liver Int; 2015 Feb; 35(2):353-61. PubMed ID: 24797536
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of portopulmonary hypertension among liver transplant candidates in a region highly endemic for viral hepatitis.
Al-Harbi A; Abdullah K; Al-Abdulkareem A; Alghamdi A; Al-Jahdali H
Ann Transplant; 2014 Jan; 19():1-5. PubMed ID: 24384535
[TBL] [Abstract][Full Text] [Related]
14. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
Awdish RL; Cajigas HR
Lung; 2013 Dec; 191(6):593-600. PubMed ID: 23979006
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Associated Factors of Portopulmonary Hypertension in Patients with Portal Hypertension: A Case-Control Study.
Shao Y; Yin X; Qin T; Zhang R; Zhang Y; Wen X
Biomed Res Int; 2021; 2021():5595614. PubMed ID: 33987440
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience.
Rajaram P; Parekh A; Fisher M; Kempker J; Subramanian R
Transplant Proc; 2017 Mar; 49(2):338-343. PubMed ID: 28219595
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of portopulmonary hypertension patients after liver transplantation.
Khaderi S; Khan R; Safdar Z; Stribling R; Vierling JM; Goss JA; Sussman NL
Liver Transpl; 2014 Jun; 20(6):724-7. PubMed ID: 24648168
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival in portopulmonary hypertension: a 20-year experience.
Aggarwal M; Li M; Bhardwaj A; Wallace WD; Wang X; Carey WD; Dweik RA; Heresi GA; Tonelli AR
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):449-456. PubMed ID: 34907982
[TBL] [Abstract][Full Text] [Related]
19. Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study.
Jose A; Rahman N; Opotowsky AR; Glorioso TJ; Waldo SW; Zeder K; Seto A; Elwing JM; McCormack FX; Maron BA
J Am Heart Assoc; 2024 Apr; 13(8):e033847. PubMed ID: 38567662
[TBL] [Abstract][Full Text] [Related]
20. Association between the albumin-bilirubin (ALBI) score and severity of portopulmonary hypertension (PoPH): A data-mining analysis.
Kawaguchi T; Honda A; Sugiyama Y; Nakano D; Tsutsumi T; Tahara N; Torimura T; Fukumoto Y
Hepatol Res; 2021 Dec; 51(12):1207-1218. PubMed ID: 34534392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
